Elsa Isingrini1, Lea Perret1, Quentin Rainer1, Sara Sagueby1, Luc Moquin1, Alain Gratton1, Bruno Giros1. 1. From the Department of Psychiatry, Douglas Mental Health research center, McGill University, Montreal, Que., Canada (Isingrini, Perret, Rainer, Sagueby, Moquin, Gratton, Giros); and ISERM, UMRS 1130; CNRS, UMR 8246; Sorbonne University UPMC, Neuroscience Paris-Seine, F-75005, Paris, France (Giros).
Abstract
BACKGROUND: The monoaminergic transmitters dopamine (DA), noradrenaline (NE) and serotonin (5-HT) modulate cerebral functions via their extensive effects in the brain. Investigating their roles has led to the creation of vesicular monoaminergic transporter-2 (VMAT2) knockout (KO) mice. While this mutation results in postnatal death, VMAT2-heterozygous (HET) mice are viable and show a complex behavioural phenotype. However, the simultaneous alteration of the 3 systems prevents investigations into their individual functions. METHODS: To assess the specific role of NE, 5-HT and DA, we genetically disrupted their neurotransmission by creating conditional VMAT2-KO mice with targeted recombination. These specific recombinations were obtained by breeding VMAT2(lox/lox) mice with DBHcre, SERTcre and DATcre mice, respectively. We conducted a complete neurochemical and behavioural characterization of VMAT2-HET animals in each system. RESULTS: Conditional VMAT2-KO mice revealed an absence of VMAT2 expression, and a specific decrease in the whole brain levels of each monoamine. Although NE- and 5-HT-depleted mice are viable into adulthood, DA depletion results in postnatal death before weaning. Interestingly, alteration of the DA transmission fully accounted for the increased amphetamine response formerly observed in the VMAT2-HET mice, whereas alteration of the 5-HT system was solely responsible for the increase in cocaine response. LIMITATIONS: We used VMAT2-HET mice that displayed a mild phenotype. Because the VMAT2-KO in DA neurons is lethal, it precluded a straightforward comparison of the full KOs in the 3 systems. CONCLUSION: Given the intermingled functions of NE, 5-HT and DA in regulating cognitive and affective functions, this model will enhance understanding of their respective roles in the pathophysiology of psychiatric disorders.
BACKGROUND: The monoaminergic transmitters dopamine (DA), noradrenaline (NE) and serotonin (5-HT) modulate cerebral functions via their extensive effects in the brain. Investigating their roles has led to the creation of vesicular monoaminergic transporter-2 (VMAT2) knockout (KO) mice. While this mutation results in postnatal death, VMAT2-heterozygous (HET) mice are viable and show a complex behavioural phenotype. However, the simultaneous alteration of the 3 systems prevents investigations into their individual functions. METHODS: To assess the specific role of NE, 5-HT and DA, we genetically disrupted their neurotransmission by creating conditional VMAT2-KO mice with targeted recombination. These specific recombinations were obtained by breeding VMAT2(lox/lox) mice with DBHcre, SERTcre and DATcre mice, respectively. We conducted a complete neurochemical and behavioural characterization of VMAT2-HET animals in each system. RESULTS: Conditional VMAT2-KO mice revealed an absence of VMAT2 expression, and a specific decrease in the whole brain levels of each monoamine. Although NE- and 5-HT-depleted mice are viable into adulthood, DA depletion results in postnatal death before weaning. Interestingly, alteration of the DA transmission fully accounted for the increased amphetamine response formerly observed in the VMAT2-HET mice, whereas alteration of the 5-HT system was solely responsible for the increase in cocaine response. LIMITATIONS: We used VMAT2-HET mice that displayed a mild phenotype. Because the VMAT2-KO in DA neurons is lethal, it precluded a straightforward comparison of the full KOs in the 3 systems. CONCLUSION: Given the intermingled functions of NE, 5-HT and DA in regulating cognitive and affective functions, this model will enhance understanding of their respective roles in the pathophysiology of psychiatric disorders.
Authors: N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl Journal: Proc Natl Acad Sci U S A Date: 1997-09-02 Impact factor: 11.205
Authors: Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron Journal: Neuron Date: 1997-12 Impact factor: 17.173
Authors: Jill Rocchetti; Elsa Isingrini; Gregory Dal Bo; Sara Sagheby; Aurore Menegaux; François Tronche; Daniel Levesque; Luc Moquin; Alain Gratton; Tak Pan Wong; Marcelo Rubinstein; Bruno Giros Journal: Biol Psychiatry Date: 2014-03-20 Impact factor: 13.382
Authors: N R Keller; A Diedrich; M Appalsamy; L C Miller; M G Caron; M P McDonald; R C Shelton; R D Blakely; D Robertson Journal: Neuroscience Date: 2006-03-03 Impact factor: 3.590
Authors: Vibeke M Bruinenberg; Els van der Goot; Danique van Vliet; Martijn J de Groot; Priscila N Mazzola; M Rebecca Heiner-Fokkema; Martijn van Faassen; Francjan J van Spronsen; Eddy A van der Zee Journal: Front Behav Neurosci Date: 2016-12-20 Impact factor: 3.558
Authors: Rachel C Branco; James P Burkett; Carlie A Black; Emily Winokur; William Ellsworth; Rohan K Dhamsania; Kelly M Lohr; Jason P Schroeder; David Weinshenker; Tanja Jovanovic; Gary W Miller Journal: Genes Brain Behav Date: 2020-01-14 Impact factor: 3.449